Mirum Pharmaceuticals
MIRM
171 hedge funds and large institutions have $1.34B invested in Mirum Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 70 increasing their positions, 52 reducing their positions, and 36 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 52
6.27% more ownership
Funds ownership: 107.84% → 114.11% (+6.3%)
7% less call options, than puts
Call options by funds: $1.79M | Put options by funds: $1.93M
9% less funds holding
Funds holding: 187 → 171 (-16)
10% less capital invested
Capital invested by funds: $1.48B → $1.34B (-$148M)
39% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 36
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$29.9M |
| 2 |
Janus Henderson Group
London,
|
+$19.4M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$17.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.9M |
| 5 |
CCM
Cadian Capital Management
New York
|
+$9.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$15.8M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.4M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$9.61M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.27M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$6.81M |
MIRM Hedge Fund Activity: Q1 2024 in Review
171 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q1 2024, worth a combined $1.34B — down 10% from $1.48B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of MIRM and 22 opened new positions — a net loss of 14 holders — while 52 trimmed existing stakes and 70 added.
The largest buyer was State Street, adding an estimated $29.9M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $15.8M sold.
- 171 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q1 2024, down from 187 in Q4 2023.
- Funds reported $1.34B of Mirum Pharmaceuticals stock for Q1 2024, down 10% quarter-over-quarter.
- 22 funds opened new Mirum Pharmaceuticals positions in Q1 2024 and 36 closed out, a net change of -14 holders.
- The largest Mirum Pharmaceuticals buyer in Q1 2024 was State Street, an estimated $29.9M added.
- The largest Mirum Pharmaceuticals seller in Q1 2024 was Perceptive Advisors, an estimated $15.8M sold.
Based on aggregated 13F filings for Q1 2024.